EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

O-GlcNAcylation of PRDX1 enhances its stability and promotes liver cancer progression via activating LRP6-mediated Wnt signaling

Luo Dai, Zheng Xu, Yin Fan, Wei Gao, Guandou Yuan, Songqing He, Linfeng Mao

Cellular Signalling · 2025-11 · 135 · 112055

DOI: 10.1016/j.cellsig.2025.112055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2025-11. Verfasst von Luo Dai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, China; Key Laboratory of E…. Hauptthemen laut MEDLINE: Liver Neoplasms, Low Density Lipoprotein Receptor-Related Protein-6, Peroxiredoxins, Wnt Signaling Pathway. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangxi Province, Guangxi Key Research and Development Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: O-GlcNAcylation, a post-translational modification intricately implicated in oncogenic processes, has garnered significant attention as a potential therapeutic target in cancer biology. Peroxiredoxin 1 (PRDX1), a master regulator of reactive oxygen species (ROS) homeostasis and antioxidant defense systems, is increasingly recognized for its contributory role in the pathogenesis of diverse malignancies. However, the functional significance of PRDX1 in liver cancer pathogenesis and the mechanistic underpinnings of its regulation remain to be fully elucidated. METHODS: In our preliminary investigations, we identified PRDX1 as a substrate amenable to O-GlcNAcylation via immunoprecipitation-mass spectrometry (IP-MS) profiling. Western blotting was performed to determine the levels of PRDX1 and O-GlcNAcylation in liver cancer tissues. Colony formation, scratch test, transwell assay and nude mouse tumor model assays were used to determine the roles of PRDX1 and O-GlcNAcylation in liver cancer progression. IP-MS was used to screen the interacting protein LRP6 of PRDX1, cycloheximide (CHX) chase assay, ubiquitination test were used to determine the stability, proximity ligation assay (PLA), immunofluorescent staining (IF) were performed the O-GlcNAcylation of PRDX1. RESULTS: Herein, we demonstrate that PRDX1 exerts profound oncogenic effects, driving liver cancer progression in both in vitro and in vivo experimental models. Notably, we reveal that PRDX1 undergoes pronounced O-GlcNAcylation in liver cancer, a modification that enhances its protein stability by attenuating ubiquitin-proteasomal degradation. Furthermore, PRDX1 interacts with low-density lipoprotein receptor-related protein 6 (LRP6), stabilizing its expression and subsequently activating the canonical Wnt/β-catenin signaling cascade. CONCLUSION: Our findings suggest that O-GlcNAcylation stabilizes PRDX1, promoting liver cancer progression. PRDX1-LRP6 interaction activates Wnt/β-catenin signaling, driving tumorigenesis. Targeting the O-GlcNAcylation-PRDX1-LRP6 axis holds therapeutic promise.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsLow Density Lipoprotein Receptor-Related Protein-6PeroxiredoxinsWnt Signaling PathwayHumansAnimalsMiceMice, NudeDisease ProgressionCell Line, TumorProtein StabilityUbiquitinationMice, Inbred BALB C

Stichwörter der Autor:innen

LRP6Liver cancerO-GlcNAcylationPRDX1Wnt pathway

Substanzen

Low Density Lipoprotein Receptor-Related Protein-6PeroxiredoxinsPRDX1 protein, humanLRP6 protein, human

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, China; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guang…

Förderung

  • Natural Science Foundation of Guangxi Province
  • Guangxi Key Research and Development Program
  • National Natural Science Foundation of China
  • Guangxi Medical University
  • Overseas Expertise Introduction Center for Discipline Innovation of Food Nutrition and Human Health
  • Ministry of Education

Zitieren

APA

Dai, L., Xu, Z., Fan, Y., Gao, W., Yuan, G., He, S., & Mao, L. (2025). O-GlcNAcylation of PRDX1 enhances its stability and promotes liver cancer progression via activating LRP6-mediated Wnt signaling. Cellular Signalling, 135, 112055. https://doi.org/10.1016/j.cellsig.2025.112055

Vancouver

Dai L, Xu Z, Fan Y, Gao W, Yuan G, He S, et al. O-GlcNAcylation of PRDX1 enhances its stability and promotes liver cancer progression via activating LRP6-mediated Wnt signaling. Cellular Signalling. 2025;135:112055. doi:10.1016/j.cellsig.2025.112055

BibTeX
@article{Dai2025,
  author = {Dai, Luo and Xu, Zheng and Fan, Yin and Gao, Wei and Yuan, Guandou and He, Songqing and Mao, Linfeng},
  title = {O-GlcNAcylation of PRDX1 enhances its stability and promotes liver cancer progression via activating LRP6-mediated Wnt signaling},
  journal = {Cellular Signalling},
  year = {2025},
  volume = {135},
  pages = {112055},
  doi = {10.1016/j.cellsig.2025.112055}
}
Kostenlos starten →